Large intestine permeability is increased in patients with compensated liver cirrhosis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 306, Issue 2, 2014, Pages

  Pijls, Kirsten E ^a,b   Koek, Ger H ^a,b   Elamin, Elhaseen E ^a,b   de Vries, Hanne ^a,b   Masclee, Ad A M ^a,b   Jonkers, Daisy M A E ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Complications; Intestinal epithelial barrier; Liver cirrhosis; Permeability; Tight junctions

Indexed keywords

CLAUDIN 3; CLAUDIN 4; LACTULOSE; OCCLUDIN; PROTEIN; RHAMNOSE; SUCROSE; TJ PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COMPENSATED LIVER CIRRHOSIS; CONTROLLED STUDY; DOWN REGULATION; DUODENUM BIOPSY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; INTESTINE MUCOSA PERMEABILITY; LARGE INTESTINE PERMEABILITY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SMALL INTESTINE PERMEABILITY; URINALYSIS; URINARY EXCRETION; YOUNG ADULT;

COMPLICATIONS; INTESTINAL EPITHELIAL BARRIER; LIVER CIRRHOSIS; PERMEABILITY; TIGHT JUNCTIONS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CLAUDIN-4; COLON, SIGMOID; DUODENUM; ENDOSCOPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTESTINE, LARGE; INTESTINE, SMALL; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OCCLUDIN; PERMEABILITY; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; TIGHT JUNCTION PROTEINS; YOUNG ADULT;

EID: 84892600598     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00330.2013     Document Type: Article

References (42)

1. Assimakopoulos SF, Tsamandas AC, Tsiaoussis GI, Karatza E, Triantos C, Vagianos CE, Spiliopoulou I, Kaltezioti V, Charonis A, Nikolopoulou VN, Scopa CD, Thomopoulos KC. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. Eur J Clin Invest 42: 439-446, 2012.
2. Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, Monteith P, Noble NA, Sikaroodi M, Gillevet PM. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 303: G675-G685, 2012.
3. Bajaj JS, Ridlon JM, Hylemon PB, Thacker LR, Heuman DM, Smith S, Sikaroodi M, Gillevet PM. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 302: G168-G175, 2012.
4. Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A. Ethanolinduced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther 291: 1075-1085, 1999.
5. Bellot P, Frances R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int 33: 31-39, 2013.
6. Benjamin J, Singla V, Arora I, Sood S, Joshi YK. Intestinal permeability and complications in liver cirrhosis: A prospective cohort study. Hepatol Res 43: 200-207, 2013.
7. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 108: 1566-1581, 1995.
8. Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol 44, Suppl 19: 23-29, 2009.
9. Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 11: 755-759, 1999.
10. Chen Y, Yang F, Lu H, Wang B, Lei D, Wang Y, Zhu B, Li L. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54: 562-572, 2011.
11. Choi Y, Jeon WK, Hwang SJ, Kim BI, Sohn CI, Park DI, Cho YK, Kim HJ, Park JH. The role of the gut barrier function in the pathophysiology of viral liver cirrhosis. Hepatogastroenterology 58: 1244-1247, 2011.
12. Colombel JF, Vaerman JP, Mesnard B, Dehennin JP, Dive C, Rambaud JC. Jejunal immunoglobulin secretion in alcoholic patients with and without cirrhosis. J Hepatol 12: 145-149, 1991.
13. Du Plessis J, Vanheel H, Janssen CE, Roos L, Slavik T, Stivaktas PI, Nieuwoudt M, van Wyk SG, Vieira W, Pretorius E, Beukes M, Farre R, Tack J, Laleman W, Fevery J, Nevens F, Roskams T, Van der Merwe SW. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol 58: 1125-1132, 2013.
14. Elamin E, Jonkers D, Troost F, Dekker J, Masclee A. Tu1352 moderate dosage of ethanol increases small and large intestinal permeability in healthy volunteers. Gastroenterology 142: S809, 2012.
15. Elamin EE, Masclee AA, Dekker J, Jonkers DM. Ethanol metabolism and its effects on the intestinal epithelial barrier. Nutr Rev 71: 483-499, 2013.
16. Ersoz G, Aydin A, Erdem S, Yuksel D, Akarca U, Kumanlioglu K. Intestinal permeability in liver cirrhosis. Eur J Gastroenterol Hepatol 11: 409-412, 1999.
17. Forsythe RM, Xu DZ, Lu Q, Deitch EA. Lipopolysaccharide-induced enterocyte-derived nitric oxide induces intestinal monolayer permeability in an autocrine fashion. Shock 17: 180-184, 2002.
18. Kalaitzakis E, Johansson JE, Bjarnason I, Bjornsson E. Intestinal permeability in cirrhotic patients with and without ascites. Scand J Gastroenterol 41: 326-330, 2006.
19. Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, Jakate S, Fields JZ. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 299: 442-448, 2001.
20. Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol 50: 538-547, 2009.
21. Lee S, Son SC, Han MJ, Kim WJ, Kim SH, Kim HR, Jeon WK, Park KH, Shin MG. Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites. World J Gastroenterol 14: 3884-3890, 2008.
22. Ma TY, Nguyen D, Bui V, Nguyen H, Hoa N. Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 276: G965-G974, 1999.
23. Moreira AP, Texeira TF, Ferreira AB, Peluzio Mdo C, Alfenas Rde C. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108: 801-809, 2012.
24. Mullin JM, Valenzano MC, Whitby M, Lurie D, Schmidt JD, Jain V, Tully O, Kearney K, Lazowick D, Mercogliano G, Thornton JJ. Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase. Aliment Pharmacol Ther 28: 1317-1325, 2008.
25. Norman K, Pirlich M, Schulzke JD, Smoliner C, Lochs H, Valentini L, Buhner S. Increased intestinal permeability in malnourished patients with liver cirrhosis. Eur J Clin Nutr 66: 1116-1119, 2012.
26. Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 32: 742-747, 2000.
27. Pascual S, Such J, Esteban A, Zapater P, Casellas JA, Aparicio JR, Girona E, Gutierrez A, Carnices F, Palazon JM, Sola-Vera J, Perez-Mateo M. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 50: 1482-1486, 2003.
28. Pijls KE, Jonkers DM, Elamin EE, Masclee AA, Koek GH. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature. Liver Int 33: 1457-1469, 2013.
29. Pinzone MR, Celesia BM, Di Rosa M, Cacopardo B, Nunnari G. Microbial translocation in chronic liver diseases. Int J Microbiol 2012: 694629, 2012.
30. Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, Kang YJ, Keshavarzian A, Rao R, Sartor RB, Swanson C, Turner JR. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42: 349-361, 2008.
31. Qin H, Zhang Z, Hang X, Jiang YL. Plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol 9: 63, 2009.
32. Robinson GM, Orrego H, Israel Y, Devenyi P, Kapur BM. Lowmolecular-weight polyethylene glycol as a probe of gastrointestinal permeability after alcohol ingestion. Dig Dis Sci 26: 971-977, 1981.
33. Scarpellini E, Valenza V, Gabrielli M, Lauritano EC, Perotti G, Merra G, Dal Lago A, Ojetti V, Ainora ME, Santoro M, Ghirlanda G, Gasbarrini A. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: Is the ring closed? Am J Gastroenterol 105: 323-327, 2009.
34. Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio Mdo C. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 32: 637-647, 2012.
35. Troost FJ, Saris WH, Brummer RJ. Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers. Eur J Clin Nutr 57: 1579-1585, 2003.
36. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799-809, 2009.
37. Van Itallie CM, Anderson JM. The molecular physiology of tight junction pores. Physiology 19: 331-338, 2004.
38. van Wijck K, van Eijk HM, Buurman WA, Dejong CH, Lenaerts K. Novel analytical approach to a multi-sugar whole gut permeability assay. J Chromatogr B Analyt Technol Biomed Life Sci 879: 2794-2801, 2011.
39. van Wijck K, Verlinden TJ, van Eijk HM, Dekker J, Buurman WA, Dejong CH, Lenaerts K. Novel multi-sugar assay for site-specific gastrointestinal permeability analysis: a randomized controlled crossover trial. Clin Nutr 32: 245-251, 2013.
40. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 41: 422-433, 2005.
41. Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2013, Epub ahead of print.
42. Zuckerman MJ, Menzies IS, Ho H, Gregory GG, Casner NA, Crane RS, Hernandez JA. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes. Dig Dis Sci 49: 621-626, 2004.